The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro

Nikolas von Bubnoff, Sivahari Prasad Gorantla, Richard A. Engh, Taianá Maia de Oliveira, Silvia Thöne, Espen Åberg, Christian Peschel, Justus Duyster

Oncogene · 2010 · 32 citations · 36 references

Concepts

References

36